Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PHILIP CREPS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1649284688
CMS profile
1150519
Location
GARDENA, CA

General Payments · PY2018–2024

$4,047.98

  • Reported across 154 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$900.37

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $900.37 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $322.79 13
Janssen Pharmaceuticals, Inc $122.50 3
Lundbeck LLC $99.56 4
Otsuka America Pharmaceutical, Inc. $93.10 4
Alkermes, Inc. $67.67 3
Almatica Pharma Inc. $55.92 2
Tris Pharma Inc $36.71 2
Biogen, Inc. $28.42 1
Axsome Therapeutics, Inc. $27.63 1
Tempus AI, Inc $23.81 1
OWP Pharmaceuticals, Inc. $22.26 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $960.70 38
PY2019 $140.61 2
PY2020 $148.47 3
PY2021 $684.30 20
PY2022 $679.06 34
PY2023 $534.47 22
PY2024 $900.37 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $32.56 01/31/2024 Food and Beverage Undisputed 01/23/2026 1103514556 CMS
ABBVIE INC. $9.41 02/05/2024 Food and Beverage Undisputed 01/23/2026 1103514558 CMS
ABBVIE INC. $9.57 03/27/2024 Food and Beverage Undisputed 01/23/2026 1103514560 CMS
ABBVIE INC. $32.93 04/29/2024 Food and Beverage Undisputed 01/23/2026 1103514562 CMS
ABBVIE INC. $24.96 05/13/2024 Food and Beverage Undisputed 01/23/2026 1103514564 CMS
ABBVIE INC. $34.21 06/20/2024 Food and Beverage Undisputed 01/23/2026 1103514566 CMS
ABBVIE INC. $33.32 06/25/2024 Food and Beverage Undisputed 01/23/2026 1103514568 CMS
ABBVIE INC. $28.52 07/30/2024 Food and Beverage Undisputed 01/23/2026 1103514570 CMS
ABBVIE INC. $26.32 08/20/2024 Food and Beverage Undisputed 01/23/2026 1103514572 CMS
ABBVIE INC. $15.58 09/17/2024 Food and Beverage Undisputed 01/23/2026 1103514574 CMS
ABBVIE INC. $29.63 09/23/2024 Food and Beverage Undisputed 01/23/2026 1103514576 CMS
ABBVIE INC. $24.81 10/27/2024 Food and Beverage Undisputed 01/23/2026 1103514578 CMS
ABBVIE INC. $20.97 11/18/2024 Food and Beverage Undisputed 01/23/2026 1103514580 CMS
Alkermes, Inc. $21.24 07/09/2024 Food and Beverage Undisputed 01/23/2026 1120484810 CMS
Alkermes, Inc. $19.39 08/27/2024 Food and Beverage Undisputed 01/23/2026 1120484812 CMS
Alkermes, Inc. $27.04 10/23/2024 Food and Beverage Undisputed 01/23/2026 1120484814 CMS
Almatica Pharma LLC $23.68 04/05/2024 Food and Beverage Undisputed 01/23/2026 1137560682 CMS
Almatica Pharma LLC $32.24 07/29/2024 Food and Beverage Undisputed 01/23/2026 1137560687 CMS
Axsome Therapeutics, Inc. $27.63 05/29/2024 Food and Beverage Undisputed 01/23/2026 1148311072 CMS
Biogen, Inc. $28.42 04/02/2024 Food and Beverage Undisputed 01/23/2026 1104824714 CMS
Janssen Pharmaceuticals, Inc $38.27 03/07/2024 Food and Beverage Undisputed 01/23/2026 1077925011 CMS
Janssen Pharmaceuticals, Inc $44.25 04/10/2024 Food and Beverage Undisputed 01/23/2026 1077924965 CMS
Janssen Pharmaceuticals, Inc $39.98 08/07/2024 Food and Beverage Undisputed 01/23/2026 1077924979 CMS
Lundbeck LLC $26.77 04/24/2024 Food and Beverage Undisputed 01/23/2026 1145907557 CMS
Lundbeck LLC $26.32 09/05/2024 Food and Beverage Undisputed 01/23/2026 1145907559 CMS
Lundbeck LLC $26.03 11/06/2024 Food and Beverage Undisputed 01/23/2026 1145907561 CMS
Lundbeck LLC $20.44 11/27/2024 Food and Beverage Undisputed 01/23/2026 1145907563 CMS
Otsuka America Pharmaceutical, Inc. $24.83 02/21/2024 Food and Beverage Undisputed 01/23/2026 1118879912 CMS
Otsuka America Pharmaceutical, Inc. $22.20 05/21/2024 Food and Beverage Undisputed 01/23/2026 1118879914 CMS
Otsuka America Pharmaceutical, Inc. $23.75 05/28/2024 Food and Beverage Undisputed 01/23/2026 1118879916 CMS
Otsuka America Pharmaceutical, Inc. $22.32 09/11/2024 Food and Beverage Undisputed 01/23/2026 1118879918 CMS
OWP Pharmaceuticals, Inc. $22.26 01/24/2024 Food and Beverage Undisputed 01/23/2026 1150025542 CMS
Tempus AI, Inc $23.81 04/03/2024 Food and Beverage Undisputed 01/23/2026 1150163060 CMS
Tris Pharma Inc $17.86 08/05/2024 Food and Beverage Undisputed 01/23/2026 1147218892 CMS
Tris Pharma Inc $18.85 09/18/2024 Food and Beverage Undisputed 01/23/2026 1147218894 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.